Mounjaro and Endometriosis: What It Can and Cannot Do

Two answers up front, because these are the questions most people want answered.

Mounjaro is not a treatment for endometriosis. It is not licensed in the UK to treat endometriosis, and there is not enough clinical evidence to say that it can treat endometriosis pain or other symptoms. You should not start Mounjaro expecting it to improve your endometriosis symptoms.

Having endometriosis does not automatically mean you cannot be prescribed Mounjaro for weight management. Endometriosis itself is not listed as a contraindication to tirzepatide. However, your prescriber needs to know about your endometriosis, the symptoms you experience and any medicines you take before deciding whether Mounjaro is suitable for you.

The important questions are what the two conditions have in common, where Mounjaro can affect your existing treatment and which symptoms need medical attention. That is what the rest of this guide covers.

Key things to know

• Endometriosis is a long term condition that can cause pelvic pain, painful periods, bowel or bladder symptoms and fatigue. It can also affect fertility.
• Mounjaro is licensed for weight management and type 2 diabetes, not for treating endometriosis.
• Some side effects of Mounjaro, such as nausea, constipation, diarrhoea and abdominal discomfort, can overlap with symptoms of endometriosis.
• Tirzepatide can affect the absorption of oral medicines. If you use an oral contraceptive, current UK product information advises using a non oral contraceptive method or adding a barrier method for 4 weeks after starting Mounjaro and for 4 weeks after each dose increase.
• Mounjaro is not recommended during pregnancy, so pregnancy planning and contraception are important parts of the discussion before starting treatment.

Does Mounjaro Help Endometriosis?

If you have searched for whether Mounjaro helps endometriosis, endometriosis pain or endometriosis symptoms, the short answer is no established benefit has been shown.

Mounjaro is not prescribed to treat endometriosis. Endometriosis care may include pain relief, hormonal treatments and, in some cases, surgery. Your GP or gynaecology team can advise which options are appropriate for your symptoms.

You may also come across the idea that losing weight could improve endometriosis because body fat can produce oestrogen. However, this does not mean that weight loss with Mounjaro will improve endometriosis. The relationship between body weight, hormones and endometriosis is more complicated than that, and there is not enough evidence to use Mounjaro as an endometriosis treatment.

If you are considering Mounjaro for weight management, it should be prescribed for that purpose rather than with the expectation that it will treat your endometriosis.

What About GLP 1 Research and Endometriosis?

You may see searches for GLP 1 medicines and endometriosis, including tirzepatide and endometriosis. Some early research has looked at whether medicines in this group could affect inflammation or other processes that may be relevant to endometriosis.

However, early laboratory or animal research is not the same as evidence from clinical studies in people. At present, there is no licensed GLP 1 medicine that is indicated to treat endometriosis.

There is also no established "best GLP 1" for endometriosis. If you are prescribed a GLP 1 medicine, the reason for treatment should be based on its licensed use and your individual clinical assessment.

You may also come across searches for "microdosing tirzepatide for endometriosis". Microdosing is not an established or licensed treatment approach for endometriosis. Do not change the dose of a prescription medicine or use it for an unlicensed purpose without advice from a qualified prescriber.

Can You Take Mounjaro If You Have Endometriosis?

Having endometriosis does not automatically rule out Mounjaro for weight management. Whether it is suitable for you depends on your overall health, medicines, symptoms and the prescribing criteria that apply.

Tell your prescriber that you have endometriosis and explain how it affects you. This is particularly important if you have bowel or bladder symptoms, have had pelvic or abdominal surgery, take hormonal treatment or are planning a pregnancy.

The Overlap Problem, and Why It Matters

This is one of the most useful things to understand if you have both conditions.

Endometriosis can cause pelvic or abdominal pain, bloating, bowel symptoms and fatigue. Mounjaro can also cause gastrointestinal side effects such as nausea, diarrhoea, constipation and abdominal discomfort. This means that some symptoms can look similar, particularly when you first start treatment or after a dose increase.

The first problem is knowing what is causing the symptom. If you feel different after starting Mounjaro, it may be a side effect, an endometriosis flare or something unrelated. It is not always possible to tell from the symptom alone.

The second problem is ignoring a new symptom because you are already used to having pain. Try to pay attention to changes from your usual pattern.

For example, if your pain feels different from your usual endometriosis pain, occurs in a new area, is unusually severe or does not settle, speak to a healthcare professional rather than assuming it is another flare.

Severe, persistent abdominal pain, particularly if it spreads to the back and occurs with vomiting, needs urgent medical assessment. Pancreatitis is a recognised but uncommon adverse effect of tirzepatide, so severe symptoms should not simply be put down to endometriosis or a normal treatment side effect.

Keeping a short note of your usual symptoms before starting Mounjaro can also help. You can record where the pain normally occurs, when it tends to happen and any usual bowel or period related symptoms. This gives you something to compare with if your symptoms change.

The Contraception Point Nobody Mentions

If you take an oral contraceptive as part of your endometriosis management, this is particularly important to discuss with your prescriber.

Tirzepatide delays gastric emptying, which can affect the absorption of some oral medicines. Current UK product information advises women who are using oral contraception and have overweight or obesity to switch to a non oral contraceptive method or add a barrier method when starting tirzepatide and for 4 weeks after each dose increase.

This can matter for more than contraception. Some people with endometriosis use hormonal contraception to help manage their symptoms. If you are taking an oral hormonal medicine, tell both the prescriber managing your Mounjaro treatment and the healthcare professional managing your endometriosis.

Do not stop or change your hormonal treatment on your own. Your clinician can explain whether you need a different option while taking Mounjaro.

Pregnancy planning is also important. Mounjaro is not recommended during pregnancy, so speak to your prescriber before starting treatment if you are trying to conceive or think you may become pregnant.

Can Mounjaro Cause or Worsen Endometriosis?

Mounjaro is not known to cause endometriosis. Endometriosis is a long term condition involving tissue similar to the lining of the womb growing outside the womb, and its exact cause is not fully understood.

There is also no established evidence that Mounjaro directly makes endometriosis itself worse. However, some Mounjaro side effects can affect the digestive system. These can include nausea, constipation, diarrhoea and abdominal discomfort. If you already have bowel or abdominal symptoms from endometriosis, these effects may feel more noticeable.

If your symptoms change after starting Mounjaro, tell your weight management prescriber. If the symptoms relate to your endometriosis, your GP or gynaecology team may also need to assess you.

Do not assume that every new symptom is caused by endometriosis or Mounjaro. A healthcare professional can help work out what may be happening and whether your treatment needs to be reviewed.

Is It Available on the NHS for Endometriosis?

If you are searching for Mounjaro for endometriosis on the NHS, the short answer is no. Mounjaro is not an NHS treatment for endometriosis because it is not licensed to treat the condition.

Mounjaro is available through NHS weight management pathways for eligible people who meet the relevant criteria. NICE recommends tirzepatide for certain adults with obesity and at least one weight related health condition, with NHS access being introduced in phases.

Endometriosis is managed through a separate healthcare pathway, usually starting with your GP and, where needed, referral to a gynaecology or specialist endometriosis service. Treatment can include medicines and surgery depending on your symptoms and circumstances.

If weight management is what you are seeking and you also have endometriosis, that is a separate reason for a Mounjaro assessment. Details of how assessment and supply work are on the Mounjaro injection for weight loss page.

Living With Both

If you are using Mounjaro for weight management while also managing endometriosis, a few simple steps may make it easier to keep track of your symptoms.

• Pay attention to changes after starting Mounjaro and after dose increases, when gastrointestinal side effects may occur.
• Track your symptoms alongside your menstrual cycle. This can help you and your healthcare team understand whether symptoms follow your usual pattern.
• Drink enough fluids, particularly if you have vomiting, diarrhoea or constipation. If you are struggling to keep fluids down, seek medical advice.
• Do not stop hormonal treatment for endometriosis just to see whether it changes Mounjaro side effects. Discuss any changes with the clinician who prescribed it.
• Tell your gynaecology team that you are taking Mounjaro, and make sure your Mounjaro prescriber knows about the medicines and treatments you receive for endometriosis.
• Seek medical advice if you develop symptoms that are new, severe or very different from your usual endometriosis symptoms.

Anyone considering Mounjaro for weight management can explore our Weight Loss Hub to learn more about the supervised options available in the UK. Mounjaro and other weight management medicines are not treatments for endometriosis.

A Word on Adenomyosis and Cure Claims

Adenomyosis and endometriosis are different conditions, although they can occur together. Adenomyosis happens when tissue similar to the lining of the womb grows into the muscular wall of the womb. It can cause heavy or painful periods and pelvic pain.

Be cautious of content promising to cure endometriosis or adenomyosis through a medicine, supplement or diet. Current NHS guidance states that there is no cure for endometriosis, although treatment can help manage symptoms. Treatment options can include pain relief, hormonal medicines and surgery, depending on the person and their symptoms.

For adenomyosis, treatment is also based on symptoms, individual circumstances and whether pregnancy is planned. A hysterectomy can be a definitive treatment option for adenomyosis for some people, but it is not appropriate for everyone and is a major surgical procedure.

Mounjaro is a weight management medicine, not a treatment or cure for endometriosis or adenomyosis. If you see claims that it can cure either condition, look for reliable medical evidence and discuss the claim with your GP or specialist before changing your treatment.

Both endometriosis and adenomyosis can have symptoms that change over time. Good care usually focuses on understanding your symptoms, managing pain and other problems, and reviewing treatment with the healthcare professional looking after you. If weight management is also part of your healthcare plan, this can be discussed separately with an appropriately qualified prescriber.

Medical Disclaimer

This page provides general information about a prescription only weight management medicine in the context of a separate gynaecological condition. It is not medical advice, it is not a treatment guide for endometriosis or adenomyosis, and Mounjaro is not licensed to treat either condition. Endometriosis is assessed and managed through your GP and gynaecology services, and the information here should not delay or replace that care.

Nothing on this page should be used to start, stop or adjust any medicine, including hormonal treatment for endometriosis. These decisions should be made with the clinician who prescribed your treatment. Information about oral contraceptive absorption reflects general UK product guidance and does not replace individual advice about your contraception or endometriosis symptom management.

If you develop severe abdominal pain that does not settle, particularly if it occurs with persistent vomiting or pain that spreads to your back, seek urgent medical attention rather than assuming it is a familiar endometriosis flare.

Suspected side effects can be reported through the MHRA Yellow Card scheme, which accepts reports from patients as well as healthcare professionals.